Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 241 - 248 of 11617 results
CMS Issues Final Notice on Program for Breakthrough Device Reimbursement but Industry Looks to Congress for More Inclusive Solution
August 19, 2024| Blog| Viewpoint
AI Is Ushering in a Tech Lawyer 'Golden Age'
August 18, 2024| News
Medicare Drug Price Cuts Add Fuel to Legal Fight Over Program
August 16, 2024| News
DOJ Issues its Highly Anticipated Whistleblower Awards Pilot Program
August 15, 2024| Blog| Viewpoint
FDA Rolls Out Innovative New Designation Programs in Response to Congressional Mandates
August 15, 2024| Blog| Viewpoint
Senate Commerce Committee Advances 10 AI Bills – AI: The Washington Report
August 14, 2024| Article| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.